1 / 6

Remdesivir Market Industry Trends And Emerging Opportunities Till 2030

Major Players in the Remdesivir Market are Gilead Sciences, Inc., Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Cipla, Pfizer, Merck, Cayman Chemical<br>Read More @ https://bit.ly/2WmAp8k

sreeramakrishnatbrc
Télécharger la présentation

Remdesivir Market Industry Trends And Emerging Opportunities Till 2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Remdesivir Market Global Report 2020-30: COVID 19 Growth And Change © The Business Research Company. All rights reserved.

  2. RemdesivirMarket Characteristics: Click Here To View Complete Report Gilead`s antiviral remdesivir is being tested in multiple phase 3 clinical trials as a treatment for moderately and severely ill COVID-19 patients. Until January, the company wasn’t manufacturing more than a few doses of its experimental antiviral remdesivir, but currently, Gilead began advancing remdesivir and is rapidly expanding its production as the research showed that remdesivir might be effective against COVID-19. Gilead spent $50 million on research and development of the drug during the first quarter. The company expects to produce more than 140,000 rounds of its 10-day treatment regimen by the end of May. Gilead released preliminary results from its clinical trial on remdesivir, showing at least 50% of the patients treated with a five-day dosage of the drug have improved. The clinical trial involved 397 patients with severe cases of COVID-19. Gilead will focus on making remdesivir both accessible and affordable to governments and patients around the world. Taking into consideration the R&D investment, and the affordable price range, the drug is expected to generate an estimated $2 billion in sales in 2020. It is expected to grow at 29.02% and reach $4.2 billion in 2023. The revenue will then drop off in subsequent years. The Business Research Company published its Remdesivir Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Remdesivir market. The report covers the Remdesivir market’s segments- by route of administration into oral, intravenous, by dosage form into tablets, frozen solution, lyophilized solution and by distribution channel into hospitals, clinics, drug stores/pharmacies, online, others. The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. © The Business Research Company. All rights reserved.

  3. Major Key Players:Gilead Sciences, Inc., Bright Gene,Hainan Haiyao, KelunPharma, Click Here To Get A Sample Report © The Business Research Company. All rights reserved.

  4. Table Of Content 1. Executive Summary 2. Remdesivir Market Characteristics 3. Remdesivir Market Size And Growth 4. Remdesivir Market Segmentation 5. Remdesivir Market Regional And Country Analysis ....... 24. Africa Remdesivir Market 25. Remdesivir Market Competitive Landscape And Company Profiles 26. Key Mergers And Acquisitions In The Remdesivir Market 27. Remdesivir Market Trends And Strategies 28. Remdesivir Market Future Outlook and Potential Analysis 29. Appendix Click Here To Get A Sample Report The Business Research Company. All rights reserved.

  5. Get In Touch Whatever your need be, at The Business Research Company we provide research consulting solutions for businesses, government agencies consultancies, and market research companies. © The Business Research Company. All rights reserved.

  6. Americas The Business Research Company 625 South Avenue, Apt B204, Secane, Philadelphia, PA 19018, USA +1 3156230293 Email: info@tbrc.info www.tbrc.info Europe The Business Research Company 47 Anchorage Point, 42 Cuba Street, Canary Wharf, London, England, E14 8NE. +44 207 1930 708 Email: info@tbrc.info www.tbrc.info Asia The Business Research Company, Horizon Avenue, 8-2-603/b/s/1/2 Road Number 10 Banjara Hills Hyderabad (India) 500033 ++91 8897263534 Email: info@tbrc.info www.tbrc.info © The Business Research Company. All rights reserved.

More Related